Discovery and characterization of AZ285 as a potent and selective inhibitor of CK2 kinase

被引：0
|
作者：
Dowling, James E. [1 ]
Alimzhanov, Marat [1 ]
Bao, Larry [1 ]
Brassil, Patrick [1 ]
Cooke, Emma L. [1 ]
Denz, Christopher R. [1 ]
Liu, Zhong-Ying [1 ]
Ye, Qing [1 ]
Lyne, Paul D. [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3907
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3907
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PK/PD/Efficacy characterization of AZ285, a selective CK2 kinase inhibitor
    Schroeder, Patricia
    Alimzhanov, Marat
    Brassil, Patrick
    Denz, Christopher R.
    Dowling, James E.
    Lyne, Paul D.
    Cooke, Emma L.
    [J]. CANCER RESEARCH, 2012, 72
  • [2] Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking
    Vangrevelinghe, E
    Zimmermann, K
    Schoepfer, J
    Portmann, R
    Fabbro, D
    Furet, P
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (13) : 2656 - 2662
  • [3] Discovery and biological characterization of CX-8184, a potent inhibitor of protein kinase CK2
    Drygin, Denis
    Bliesath, Joshua
    Huser, Nanni
    Proffitt, Chris
    Siddiqui-Jain, Adam
    Omori, Mayuko
    Stansfield, Ryan
    Macalino, Diwata
    O'Brien, Sean E.
    Lim, John K. C.
    Rice, William G.
    Ryckman, David M.
    [J]. CANCER RESEARCH, 2012, 72
  • [4] Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
    Cozza, Giorgio
    Mazzorana, Marco
    Papinutto, Elena
    Bain, Jenny
    Elliott, Matthew
    Di Maira, Giovanni
    Gianoncelli, Alessandra
    Pagano, Mario A.
    Sarno, Stefania
    Ruzzene, Maria
    Battistutta, Roberto
    Meggio, Flavio
    Moro, Stefano
    Zagotto, Giuseppe
    Pinna, Lorenzo A.
    [J]. BIOCHEMICAL JOURNAL, 2009, 421 : 387 - 395
  • [5] Novel potent and selective inhibitors of protein kinase CK2
    Prudent, R.
    Moucadel, V
    Laudet, B.
    Cochet, C.
    [J]. BULLETIN DU CANCER, 2008, 95 : S66 - S66
  • [6] Development of a potent and selective chemical probe for the pleiotropic kinase CK2
    Wells, Carrow, I
    Drewry, David H.
    Pickett, Julie E.
    Tjaden, Amelie
    Kraemer, Andreas
    Mueller, Susanne
    Gyenis, Laszlo
    Menyhart, Daniel
    Litchfield, David W.
    Knapp, Stefan
    Axtman, Alison D.
    [J]. CELL CHEMICAL BIOLOGY, 2021, 28 (04): : 546 - +
  • [7] Hypericin, a selective Inhibitor of the catalytic subunit of protein kinase CK2
    Noske, Katharina
    Brunstein, Elena
    Rasmussen, Tine
    Niefind, Karsten
    Issinger, Olaf-Georg
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S7 - S7
  • [8] Discovery and characterization of AZ6197, a potent and selective ERK1/2 inhibitor
    Flemington, Vikki
    Simpson, Iain
    Davies, Emma
    Robinson, David
    Lindsay, Nicola
    Hanson, Lyndsey
    Hopcroft, Philip
    Tonge, Michael
    Roberts, Karen
    Ward, Richard
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [9] In Vitro and In Silico Evaluation of Bikaverin as a Potent Inhibitor of Human Protein Kinase CK2
    Haidar, Samer
    Aichele, Dagmar
    Birus, Robin
    Hielscher, Janine
    Laitinen, Tuomo
    Poso, Antti
    Jose, Joachim
    [J]. MOLECULES, 2019, 24 (07):
  • [10] Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2
    Gianoncelli, Alessandra
    Cozza, Giorgio
    Orzeszko, Andrzej
    Meggio, Flavio
    Kazimierczuk, Zygmunt
    Pinna, Lorenzo A.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7281 - 7289
12345